SOPHiA GENETICS (SOPH) Exec Chairman Jurgi Camblong Sells Shares

What Happened
Jurgi Camblong, Executive Chairman and Director of SOPHiA GENETICS SA (SOPH), sold a total of 28,500 common shares in two open-market transactions. On 2026-08-07 he disposed of 20,000 shares at a weighted average price of $7.23 for proceeds of $144,540 (sales prices ranged $7.20–$7.27). On 2026-08-10 he disposed of 8,500 shares at a weighted average price of $7.61 for proceeds of $64,669 (sales prices ranged $7.50–$7.80). Combined proceeds were about $209,209. These were sales (not purchases or option exercises).

Key Details

• Transaction dates and prices:
  • 2026-08-07: 20,000 shares sold, weighted avg $7.23 (range $7.20–$7.27) — $144,540.
  • 2026-08-10: 8,500 shares sold, weighted avg $7.61 (range $7.50–$7.80) — $64,669.
• Total shares sold: 28,500; total proceeds ≈ $209,209.
• Shares owned after transaction: Not disclosed in the information provided on this filing.
• Notable footnotes:
  • F1: Transactions made pursuant to a pre-established Rule 10b5-1 trading plan.
  • F2/F3: Reported prices are weighted averages; per-footnote ranges show exact trade price bands and offer to provide per-price breakdown on request.
• Timeliness: Form filed 2026-08-10 for transactions on 2026-08-07 — appears to be filed within the standard reporting window.

Context
These transactions were sales under a 10b5-1 trading plan, which allows insiders to sell shares according to a pre-set plan and is commonly used to avoid timing-related issues. Sales do not necessarily indicate a change in insider sentiment about the company; they are often routine portfolio or liquidity actions.